REG-BARCLAYS PLC Form 38.5 (b) OSMOTICA
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201218:nBw15HcFda&default-theme=true
Form 38.5 (b) OSMOTICA
Ap27
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY
STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A
CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader: BARCLAYS CAPITAL INC
Company dealt in OSMOTICA PHARMACEUTICALS PLC
Class of relevant security to which the US$0.01 ordinary shares
dealings being disclosed relate
Date of dealing 17 December 2020
2. INTERESTS AND SHORT POSITIONS
a. Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 2)
Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
320 0.00% 343 0.00%
(2) Derivatives (other than options):
0 0.00% 0 0.00%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL: 320 0.00% 343 0.00%
b. Interests and short positions in relevant securities of the company,
otherthan the class dealt in (Note 2)
Ap28
3. DEALINGS (Note 3)
a. Purchases and sales
Purchase/sale Number of Price per unit
securities
Purchase 100 5.8300 USD
Purchase 100 5.9700 USD
Purchase 336 5.9310 USD
Purchase 600 5.9258 USD
Purchase 764 5.8889 USD
Sale 1,900 5.9092 USD
b. Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 5) (Note 6) (Note 4)
c. Options transactions in respect of existing relevant securities
1. Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 4)
e.g. call option
i. Exercising
Product name, Number of securities Exercise price per unit (Note 4)
e.g. call option
d. Other dealings (including transactions in respect of new securities) (Note
3)
Nature of transaction Details Price per unit
(Note 7) (if applicable) (Note 4)
Ap29
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
Attachments
Is a Supplemental Form 38.5(b) attached? NO
Date of disclosure: 18 Dec 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
Name of offeree/offeror with which connected
Nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201218005219/en/
(https://www.businesswire.com/news/home/20201218005219/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Barclays PLC Just Group plc - Form 8.3 JUST GROUP PLC
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
Announcement